RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

Stronger technical forecast for BioTime, Inc stock price after Thursday trading.
(Updated on Sep 24, 2020)

Buy candidate since Sep 24, 2020 PDF

The BioTime, Inc stock price gained 1.28% on the last trading day (Thursday, 24th Sep 2020), rising from $0.92 to $0.93. During the last trading day the stock fluctuated 8.05% from a day low at $0.87 to a day high of $0.94. The price has risen in 7 of the last 10 days and is up by 4.12% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 501 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $1.08 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 16.81% during the next 3 months and, with a 90% probability hold a price between $1.02 and $1.29 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

BTX Signals & Forecast

Mostly positive signals in the chart today. The BioTime, Inc stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $1.00. On a fall, the stock will find some support from the long-term average at approximately $0.93. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. A buy signal was issued from a pivot bottom point on Wednesday, September 23, 2020, and so far it has risen 1.28%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). BioTime, Inc has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk.

Support, Risk & Stop-loss for BioTime, Inc stock

BioTime, Inc finds support from accumulated volume at $0.92 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.0700 between high and low, or 8.05%. For the last week, the stock has had daily average volatility of 9.82%.

Our recommended stop-loss: $0.88 (-5.41%) (This stock has high daily movements and this gives high risk. There is a buy signal from a pivot bottom found 1 day ago.)

Trading Expectations (BTX) For The Upcoming Trading Day Of Friday 25th

For the upcoming trading day on Friday, 25th we expect BioTime, Inc to open at $0.91, and during the day (based on 14 day Average True Range), to move between $0.86 and $1.01, which gives a possible trading interval of +/-$0.0760 (+/-8.15%) up or down from last closing price. If BioTime, Inc takes out the full calculated possible swing range there will be an estimated 16.30% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $0.94 (0.67%) than the support at $0.92 (1.81%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is BioTime, Inc stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for BioTime, Inc stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

Current score: 4.874 Buy Candidate Upgraded

Predicted Opening Price for BioTime, Inc of Friday, September 25, 2020

Fair opening price September 25, 2020 Current price
$0.91 ( 1.92%) $0.93

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for BTX

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.98 5.59 %
R2 0.96 2.72 %
R1 0.94 0.95 %
Current price: 0.93
Support S1 0.89 -4.79 %
S2 0.87 -6.57 %
S3 0.84 -9.44 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 1.05 12.67 %
R2 0.98 5.16 %
R1 0.94 0.665 %
Current price 0.93
Support S1 0.92 -1.81%
S2 0.90 -3.42%
S3 0.790 -15.23%

FAQ

What is the symbol for BioTime, Inc Stock and on which exchange is it traded?
The symbol for BioTime, Inc is BTX and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell BioTime, Inc Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for BioTime, Inc stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Buy candidate.

How to buy BioTime, Inc Stock?
BioTime, Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy BioTime, Inc Stock.

What's the current price of BioTime, Inc Stock?
As of the end of day on the 2020-09-24, the price of an BioTime, Inc (BTX) share was $0.93.

What is the 52-week high and low for BioTime, Inc Stock?
The 52-week high for BioTime, Inc Stock is $1.67 and the 52-week low is $0.534.

What is the market capitalization of BioTime, Inc Stock?
As of the 2020-09-24, the market capitalization of BioTime, Inc is 1.052M.
Click to get the best stock tips daily for free!

About BioTime, Inc

BioTime Brooklyn ImmunoTherapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing therapies to treat patients with cancer. Its advanced program is IRX-2 that is in a Phase 2b clinical trial in patients with squamous cell cancer of the head and neck. The company also develops therapies using gene-editing and cell therapy technology for the treatment of oncology, blood disorder, and monogenic disease. Brooklyn ImmunoTherapeutics,... BTX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT